Oladapo Yeku
0000-0002-6319-1647
Publication & Citation Trends
Publications
0 total
Normalizing the Tumor Microenvironment: A New Frontier in Ovarian Cancer Therapy
Cited by 0
Semantic Scholar
Targeting the disrupted Hippo signaling to prevent neoplastic renal epithelial cell immune evasion OA
Cited by 9
Semantic Scholar
Hypoxia induced VEGF secretion promotes resistance to bispecific T-cell engagers
Cited by 1
Semantic Scholar
Serial Circulating Tumor DNA Sequencing to Monitor Response and Define Acquired Resistance to Letrozole/Abemaciclib in Endometrial Cancer
Cited by 5
Semantic Scholar
Myeloid targeting antibodies PY159 and PY314 for platinum-resistant ovarian cancer OA
Cited by 9
Semantic Scholar
Abstract B086: Anchored in Resistance: Overcoming Nidogen-2 (NID2) - mediated Immunoresistance in Ovarian Cancer with Ras and Bcl-xl Inhibition
Cited by 0
Semantic Scholar
Abstract IA012: Mechanisms and consequences of bispecific T-cell engager immunotherapy for ovarian cancer
Cited by 0
Semantic Scholar
Research Topics
CAR-T cell therapy research
(33)
Ovarian cancer diagnosis and treatment
(30)
Cancer Immunotherapy and Biomarkers
(28)
Monoclonal and Polyclonal Antibodies Research
(22)
Radiopharmaceutical Chemistry and Applications
(17)
Affiliations
Memorial Sloan Kettering Cancer Center
Harvard University
MGH Institute of Health Professions
University of Pittsburgh
University of Washington